-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE ANNOUNCES IRB APPROVAL FOR PHASE 1/2A CLINICAL TRIAL FOR ALCOHOL USE DISORDER AT TEL AVIV SOURASKY MEDICAL CENTER

Reuters·07/03/2025 12:47:00

Please log in to view news